NOV 06, 2019 6:00 AM PST

Understanding the Pathogenesis of Human Influenza Virus: A Systems Virology Approach

Presented at: Influenza 2019
C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Associate Professor, Laboratory of Molecular Virology, Department of Pediatric Infectious Diseases and Immunology, School of Medicine, Pontificia Universidad Catolica de Chile
    Biography
      Dr. Medina is Associate professor in the Department of Pediatric Infectious Diseases and Immunology at the School of Medicine at Pontificia Universidad Catolica de Chile in Santiago. His laboratory studies the molecular biology and ecology of Influenza virus encompassing three mayor areas of research: i) Translational studies to investigate molecular factors of the virus and the host that contribute to disease severity. This includes studying host-pathogens interactions, immune responses, elucidating pathogenesis factors and determining the role of the microbiome during respiratory IAV infection. ii) Characterization of the antigenic properties of the Hemagglutinin (HA) protein of IAV and its role in pathogenesis. This involves studying how specific changes in glycosylations affect the antigenicity and virulence of the virus, and their role in modulating innate, and humoral immune responses. These studies are aimed at contributing to better define epitopes with broad-spectrum antigenic characteristics, which might be relevant for vaccine development. iii) Investigate the ecology of emerging viruses in Chile and Antarctica. This includes developing improved diagnostic tools, sequencing pipelines and analyses platforms to perform long-term molecular epidemiology for the study of influenza virus in natural reservoirs. The overall aim is to gain a better understanding of the viral genetic pool in nature and the ecological niches that contribute to spill over events that generate outbreaks, epidemics and potentially pandemics. These overarching research themes provide an in depth and integrated approach to elucidate the viral and host molecular factors involved in infection and disease caused by emerging pathogens.

    Abstract

    Multiple factors can affect and impact infection dynamics and virulence produced by influenza virus (IV) infections. Susceptibility factors and host responses can also have major effects in disease severity. It has become apparent that innate and adaptive immune responses can modulate clinical evolution to infection, which is directly and indirectly modulated by factors such as pre-existing conditions and host and virus genetic background. Thus, a major leap forward lies in understanding and integrating global virus-host interactions. To identify viral and host molecular markers of disease severity and outcome we investigated IV diversity and evolution and host responses to infection. Hence, we evaluated the status of the innate and adaptive immune responses, and established clinical parameters associated with poor outcome. A comprehensive multiscale analysis of clinical metadata and cytokine profiling, revealed that comorbidities such as arterial hypertension, chronic cardiovascular disease and obesity, together with early increased expression of pro-inflammatory cytokines, including of IL-6, 8 and the anti-inflammatory IL-10, were associated with severity. Additionally, we used next generation sequencing and developed bioinformatics tools to investigate viral diversity and to evaluate different IV variants obtained from severe individuals. We identified a number of transitional amino acid changes over time in functional sites. Notably, we found two novel mutations of epidemiological relevance in the viral glycoproteins. The I223M mutation on the Neuraminidase was found to confer resistance to the antiviral oseltamivir, whereas a K180Q residue change in a major antigenic site of the Hemagglutinin was found to contribute to the evasion of preexisting immunity (antibody responses). These changes occurred independently in severe subjects and were detected as mixed populations in sequential samples, indicating a dynamic change in the IV genome over time. Overall, our systematic approach suggests that early aberrant immune responses and increased viral diversity in susceptible individuals can play a crucial role in disease outcome. This translational virology approach allows us to interrogate complex biological systems in depth, to define and dissect the global molecular processes involved in viral infection and disease.
    FUNDING: FONDECYT 1121172, 1161791 and PIA-ACT 1408 from CONICYT, the Chilean Ministry of Economy, Development and Tourism, P09/016-F, the Center for Research in Influenza Pathogenesis (CRIP) HHSN272201400008C and grant U19AI135972 both from NIH-NIAID

    Learning Objectives:
    1. To identify what factors can contribute to disease severity during Influenza virus infection.
    2. To describe novel techniques and methodologies used to study viral-host interactions.

     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    JUN 09, 2021 7:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
    DEC 02, 2020 8:00 AM PST
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    MAR 16, 2021 10:00 AM PDT
    C.E. CREDITS
    MAR 16, 2021 10:00 AM PDT
    Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
    APR 21, 2021 10:00 AM PDT
    C.E. CREDITS
    APR 21, 2021 10:00 AM PDT
    Date: April 21, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Serological testing for SARS-CoV-2 has been steadily adopted into clinical practice over the course of this pandemic. In this webinar,...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    NOV 06, 2019 6:00 AM PST

    Understanding the Pathogenesis of Human Influenza Virus: A Systems Virology Approach

    Presented at: Influenza 2019
    C.E. Credits: P.A.C.E. CE Florida CE

    Specialty

    Immunology

    Molecular Biology

    Clinical Diagnostics

    Molecular Diagnostics

    Microbiology

    Laboratory Testing

    Diagnostics

    Biomarkers

    Biotechnology

    Pcr/rt-Pcr/real-Time Pcr

    Cell Biology

    Infectious Disease

    Biochemistry

    Dna

    Biology

    Geography

    North America59%

    Asia32%

    Europe5%

    South America5%

    Registration Source

    Website Visitors95%

    Email Promotions5%

    Job Title

    Clinical Laboratory Scientist25%

    Medical Laboratory Technician20%

    Educator/Faculty10%

    Student10%

    Medical Doctor/Specialist5%

    Executive5%

    Biologist5%

    QC/QA5%

    Research Scientist5%

    Veterinarian5%

    Scientist5%

    Organization

    Academic Institution27%

    Clinical Laboratory23%

    Hospital18%

    Biotech Company9%

    Veterinary School5%

    Manufacturer - Other5%

    Medical School5%

    Ambulatory Care5%

    Pharmaceutical Company5%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more